CoStar Group, Inc. CSGP
Verdict: Sell. Fair value $72.05 against a price of $66.42 on 6 Jan 2026, 8% above the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: In 2024, Net Income plummeted 62% (from $0.37B to $0.14B) while Operating Cash Flow only declined....
Main risks
- Collapsing Profitability and Negative Free Cash Flow: Despite double-digit revenue growth, Net Income fell by 62% in the latest year (2024 vs 2023) and TTM Free Cash Flow is negative ($-40M), indicating severe margin pressure or inefficient capital spending.
- Extremely Poor Return on Incremental Capital (ROIIC): The estimated 3-year ROIIC is sharply negative (-45.9%), suggesting that capital invested over the last three years has been value-destructive. This is a major red flag regarding capital allocation strategy.
- Deteriorating Returns on Capital: Current ROE (1.9%), ROA (1.5%), and ROIC (1.3%) are exceptionally low, indicating the company is failing to generate adequate profits from its large and growing capital base.
- In 2024, Net Income plummeted 62% (from $0.37B to $0.14B) while Operating Cash Flow only declined...
- Valuation prices in optimistic scenario (limited margin for error)
- In 2024, Net Income plummeted 62% (from $0.37B to $0.14B) while Operating Cash Flow only declined 20% (from $0.49B to $0.39B). This massive divergence (OCF/NI ratio of 2.83) strongly indicates that a large non-cash expense, such as an impairment, restructuring charge, or asset write-down, significantly impacted reported GAAP earnings. While cash flow is strong, the quality and volatility of reported net income are a concern.